Most-enhancing tumor volume by MRI radiomics predicts recurrence-free survival “early on” in neoadjuvant treatment of breast cancer

BACKGROUND: The hypothesis of this study was that MRI-based radiomics has the ability to predict recurrence-free survival “early on” in breast cancer neoadjuvant chemotherapy. METHODS: A subset, based on availability, of the ACRIN 6657 dynamic contrast-enhanced MR images was used in which we analyze...

Descripción completa

Detalles Bibliográficos
Autores principales: Drukker, Karen, Li, Hui, Antropova, Natalia, Edwards, Alexandra, Papaioannou, John, Giger, Maryellen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899353/
https://www.ncbi.nlm.nih.gov/pubmed/29653585
http://dx.doi.org/10.1186/s40644-018-0145-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899353/
https://www.ncbi.nlm.nih.gov/pubmed/29653585
http://dx.doi.org/10.1186/s40644-018-0145-9

Ejemplares similares